Lihong Weng MD, PhD

Lihong Weng has completed her MD from Kiel University, Germany and postdoctoral studies from City of Hope, USA. Currently, she is working on identifying tumor related antigens and the biology function of engineered T CAR cells in Departments of Hematology & Hematopoietic Cell Transplantation and Cancer Immunotherapy & Tumor Immunology.